SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-20-048247
Filing Date
2020-04-17
Accepted
2020-04-17 16:56:10
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 tm2016274d1_424b3.htm 424B3 528063
2 GRAPHIC tm2013443d1_f3sp1-img001.jpg GRAPHIC 14892
3 GRAPHIC tm2013443d1_f3sp1-img002.jpg GRAPHIC 13402
  Complete submission text file 0001104659-20-048247.txt   568530
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 424B3 | Act: 33 | File No.: 333-237389 | Film No.: 20800333
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences